On March 23, 2023, InnoTherapy, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,770 KRW | -0.57% | +0.46% | -1.13% |
1st Jan change | Capi. | |
---|---|---|
-1.13% | 46.68M | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-12.92% | 32.81B | |
+53.99% | 25B | |
-16.51% | 15.29B | |
-8.27% | 12.93B | |
-42.60% | 11.61B | |
-12.82% | 11.49B | |
+2.77% | 8.98B |
- Stock Market
- Equities
- A246960 Stock
- News SCL Science Inc.
- InnoTherapy, Inc. announced that it has received KRW 4.999995 billion in funding from SCL Healthcare Co., Ltd., Seoul Clinical Laboratories